Evaluation of the clinical efficacy of a phytotherapeutic drug in the treatment and prevention of recurring acute rhinosinusitis in children of Chelyabinsk

Abstract

The article presents the results of own study of clinical efficacy of myrtol standardized in the treatment of relapses of acute rhinosinusitis in children. The study included patients with acute rhinosinusitis confirmed clinically and instrumentally. The comparative open study using clinical, laboratory, biochemical, immunological and statistical methods was conducted in January – March and September – November 2015. 73 patients (mean age – 9,5 ± 3) were examined and treated. In group 1 (nasal irrigation by Proetz), improvement in patients according to the VAS was achieved on day 4 of disease. In group 2 (receiving GeloMyrtol®), improvement was observed on day 3 of disease. The period of recovery in group 1 was more than 8 days, in group 2 – less than 6–7 days.

Keywords

• acute rhinosinusitis
• children
• treatment
• myrtol standardized
• gelomyrtol® phytopreparation
• gelomyrtol®forte.